- Home
- GORV vs TPST Comparison
GORV vs TPST Comparison
Compare GORV & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- TPST
- Stock Information
- Founded
- GORV 1976
- TPST 2011
- Country
- GORV United States
- TPST United States
- Employees
- GORV N/A
- TPST N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- TPST Health Care
- Exchange
- GORV Nasdaq
- TPST Nasdaq
- Market Cap
- GORV 25.3M
- TPST 33.0M
- IPO Year
- GORV 2015
- TPST N/A
- Fundamental
- Price
- GORV $0.23
- TPST $7.08
- Analyst Decision
- GORV Hold
- TPST Hold
- Analyst Count
- GORV 2
- TPST 3
- Target Price
- GORV $2.00
- TPST $30.00
- AVG Volume (30 Days)
- GORV 2.7M
- TPST 241.4K
- Earning Date
- GORV 08-15-2025
- TPST 08-07-2025
- Dividend Yield
- GORV N/A
- TPST N/A
- EPS Growth
- GORV N/A
- TPST N/A
- EPS
- GORV N/A
- TPST N/A
- Revenue
- GORV $767,257,000.00
- TPST N/A
- Revenue This Year
- GORV $15.65
- TPST N/A
- Revenue Next Year
- GORV $20.54
- TPST N/A
- P/E Ratio
- GORV N/A
- TPST N/A
- Revenue Growth
- GORV N/A
- TPST N/A
- 52 Week Low
- GORV $0.13
- TPST $5.35
- 52 Week High
- GORV $3.56
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- GORV 45.41
- TPST 50.32
- Support Level
- GORV $0.21
- TPST $6.73
- Resistance Level
- GORV $0.27
- TPST $7.18
- Average True Range (ATR)
- GORV 0.02
- TPST 0.29
- MACD
- GORV 0.00
- TPST 0.00
- Stochastic Oscillator
- GORV 37.10
- TPST 78.01
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.